APPROVED USE UZEDY ® (risperidone) extended-release injectable suspension is a prescription medicine used in adults. for the treatment of schizophrenia for the maintenance treatment of bipolar I …

UZEDY (risperidone) extended-release injectable suspension for subcutaneous use is indicated in adults for the treatment of schizophrenia and as monotherapy or as adjunctive therapy to lithium or …

Compared to placebo, risperidone extended-release injection (Uzedy®) once monthly and once every two months have been shown to significantly prolong time to relapse in patients with schizophrenia.

Oct 7, 2024 · Uzedy is an injection that contains the antipsychotic medicine risperidone. Uzedy helps control psychotic symptoms of schizophrenia, such as hallucinations and delusions.

Oct 14, 2025 · Uzedy is a long-acting injectable form of risperidone that is used to treat adults with schizophrenia or bipolar I disorder.

If you take Perseris® (risperidone long-acting injection), it is not recommended to take oral risperidone after the first injection. Antipsychotic treatment is generally needed lifelong for persons with …

Indication(s) Under Review in This Document1 • Risperidone SC 1-2 month (UZEDY) is indicated for the treatment of schizophrenia in adults.

Uzedy, an extended-release, subcutaneous (SC) formulation of the second-generation antipsychotic drug risperidone, was approved by the FDA in 2023 for treatment of schizophrenia in adults. It has …

Jan 24, 2025 · UZEDY is indicated for the treatment of schizophrenia in adults. 2 DOSAGE AND ADMINISTRATION 2.1 Recommended Dosage For patients who have never taken risperidone, …

The SHINE study, a 56-week open-label trial, evaluated Uzedy's safety and tolerability among 336 schizophrenia patients also stable on oral risperidone for at least four months. Patients received …